and specific aims): The gas-exchange surface of the lung is continuously challenged by inhaled particulate antigens, however, the generation of a T-cell mediated immune response within the lung is uncommon. The development of a pulmonary immune response reflects the net effects of proinflammatory and suppressive activities by immune cells in the lung. In this regard, alveolar macrophages (AM) play a pivotal role in the response to particulates by ingesting and sequestering them away from immune cells in the lung interstitium. Activated AM also secrete factors that effectively suppress the activities of antigen presenting cells (APC) and the proliferation of T-cells. Dendritic cells (DC) distributed in the airway and pulmonary interstitium entrap inhaled soluble antigens and present them to T-cells in draining lymph nodes and lung. Although DC show limited phagocytosis, they can present particulate antigens to T-cells in vitro. The broad goal of this project is to understand how macrophages interact with DC and T-cells during a particulate antigen challenge to suppress the immune response in vivo. This project will address the following questions:
Aim 1. How do soluble and particulate antigens differ in their abilities to promote NO production by AM? Aim 2. How does NO suppress the activities of lung DC and T-cells? Aim 3. How do phagocytosis and NO production by AM in vivo contribute to the development of immune """"""""tolerance"""""""" to particulate antigens?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI039054-04
Application #
6163706
Study Section
Special Emphasis Panel (ZRG2-RAP (01))
Program Officer
Adams, Ken
Project Start
1997-03-01
Project End
2001-02-28
Budget Start
2000-03-01
Budget End
2001-02-28
Support Year
4
Fiscal Year
2000
Total Cost
$287,266
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Tager, Andrew M; Kradin, Richard L; LaCamera, Peter et al. (2004) Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. Am J Respir Cell Mol Biol 31:395-404
Jain, Felipe A; Zhao, Long-Hai; Selig, Martin K et al. (2003) Epinephrine promotes pulmonary angiitis: evidence for a beta1-adrenoreceptor-mediated mechanism. Am J Physiol Lung Cell Mol Physiol 285:L232-9
Sakamoto, Hideo; Zhao, Long-Hai; Jain, Felipe et al. (2002) IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis. Exp Mol Pathol 72:1-9
Tager, A M; Luster, A D; Leary, C P et al. (1999) Accessory cells with immunophenotypic and functional features of monocyte-derived dendritic cells are recruited to the lung during pulmonary inflammation. J Leukoc Biol 66:901-8
Tager, A; Luster, A; Kradin, R (1999) T-cell chemokines interferon-inducible protein-10 and monokine induced by interferon-gamma are upregulated in bleomycin-induced lung injury. Chest 116:90S